Healthcare provider profile · identity verified

Dushyant Rameshchandra Patel, MD

Internal Medicine · FAIR LAWN, NJ · NPI 1750330072

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	857	196
Rosuvastatin Calcium	Rosuvastatin Calcium	572	167
Amlodipine Besylate	Amlodipine Besylate	558	163
Metoprolol Succinate	Metoprolol Succinate	489	133
Levothyroxine Sodium	Levothyroxine Sodium	458	113
Metformin Hcl	Metformin Hcl	452	122
Clopidogrel	Clopidogrel Bisulfate	341	56
Pantoprazole Sodium	Pantoprazole Sodium	337	105
Tamsulosin Hcl	Tamsulosin Hcl	224	61
Losartan Potassium	Losartan Potassium	214	66
Eliquis	Apixaban	213	39
Lisinopril	Lisinopril	200	41
Furosemide	Furosemide	193	69
Metoprolol Tartrate	Metoprolol Tartrate	186	42
Glimepiride	Glimepiride	181	48
Finasteride	Finasteride	167	30
Hydrochlorothiazide	Hydrochlorothiazide	163	54
Famotidine	Famotidine	147	47
Olmesartan Medoxomil	Olmesartan Medoxomil	141	40
Omeprazole	Omeprazole	128	36
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	127	33
Januvia	Sitagliptin Phosphate	116	32
Carvedilol	Carvedilol	107	40
Divalproex Sodium	Divalproex Sodium	107	12
Jardiance	Empagliflozin	106	28
Gabapentin	Gabapentin	102	39
Metformin Hcl Er	Metformin Hcl	102	25
Alendronate Sodium	Alendronate Sodium	97	32
Levetiracetam	Levetiracetam	95	14
Mirtazapine	Mirtazapine	91	20
Myrbetriq	Mirabegron	90	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	88	69
Pravastatin Sodium	Pravastatin Sodium	83	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	23
Escitalopram Oxalate	Escitalopram Oxalate	80	14
Vitamin D2	Ergocalciferol (Vitamin D2)	80	26
Allopurinol	Allopurinol	74	18
Duloxetine Hcl	Duloxetine Hcl	60	18
Hydralazine Hcl	Hydralazine Hcl	60	23
Meloxicam	Meloxicam	60	51
Methylprednisolone	Methylprednisolone	59	49
Midodrine Hcl	Midodrine Hcl	58	21
Carbidopa-Levodopa	Carbidopa/Levodopa	57	suppressed
Donepezil Hcl	Donepezil Hcl	56	suppressed
Prednisone	Prednisone	56	38
Isosorbide Mononitrate Er	Isosorbide Mononitrate	55	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	13
Glipizide Er	Glipizide	51	11
Tramadol Hcl	Tramadol Hcl	51	18
Farxiga	Dapagliflozin Propanediol	49	19
Montelukast Sodium	Montelukast Sodium	49	12
Ramipril	Ramipril	49	15
Sucralfate	Sucralfate	48	suppressed
Xarelto	Rivaroxaban	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	31
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Oxycodone Hcl	Oxycodone Hcl	45	suppressed
Albuterol Sulfate	Albuterol Sulfate	44	11
Brilinta	Ticagrelor	44	suppressed
Clonazepam	Clonazepam	44	15
Breo Ellipta	Fluticasone/Vilanterol	43	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	43	14
Lactulose	Lactulose	42	14
Alcohol Prep Pads	Alcohol Antiseptic Pads	40	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	40	12
Diclofenac Sodium	Diclofenac Sodium	40	18
Novolog Flexpen	Insulin Aspart	40	suppressed
Azithromycin	Azithromycin	39	34
Buspirone Hcl	Buspirone Hcl	39	suppressed
Topiramate	Topiramate	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Atenolol	Atenolol	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	14
Pregabalin	Pregabalin	37	14
Budesonide	Budesonide	36	suppressed
Memantine Hcl	Memantine Hcl	35	11
Olanzapine	Olanzapine	35	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	33	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	11
Acetylcysteine	Acetylcysteine	30	suppressed
Briviact	Brivaracetam	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Entresto	Sacubitril/Valsartan	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	23
Diltiazem Hcl	Diltiazem Hcl	28	suppressed
Cephalexin	Cephalexin	27	21
Ozempic	Semaglutide	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	11
Clonidine Hcl	Clonidine Hcl	25	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	20
Carbamazepine Er	Carbamazepine	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	22	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	22	suppressed
Carbamazepine	Carbamazepine	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Nystatin	Nystatin	21	11
Valsartan	Valsartan	21	suppressed
Ranolazine Er	Ranolazine	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Clonidine	Clonidine	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Folic Acid	Folic Acid	16	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	16	suppressed
Methadone Hcl	Methadone Hcl	16	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Dexamethasone	Dexamethasone	13	13
Digoxin	Digoxin	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Tradjenta	Linagliptin	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Sodium Chloride	0.9 % Sodium Chloride	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Colchicine	Colchicine	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error